Overcoming Scalability Challenges in Viral Vector Manufacturing

Scaling viral vector manufacturing from early development to commercial supply is one for gene therapy’s greatest hurdles. In this webinar, Emigdio Reyes, PhD, breaks down the key bottlenecks across upstream and downstream processes, and shares practical strategies to improve yields, reduce costs, and navigates regulatory complexity.

Featuring two real-world case studies, including an AAV scale-up to 2,000 L, this webinar delivers actionable insights for manufacturing, CMC, tech ops, and regulatory professionals.

Register to learn how to scale smarter and bring gene therapies to patients faster.